Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Siva Raja, MD, PhD, is a thoracic surgeon in the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board certified in surgery, and his specialty interests include lung and esophageal cancer.
Dr. Raja earned his medical degree and a PhD in molecular and cellular pathology from the University Of Pittsburgh School Of Medicine. During his medical school career, Dr. Raja completed one-year research fellowships in thoracic surgery at the University of Pittsburgh Medical Center and with the National Institute for Diabetes, Digestive and Kidney Diseases at Vanderbilt University, Nashville, Tenn. For his post-graduate training, Dr. Raja completed a general surgery residency at Brigham and Women’s Hospital, Boston, where he was named Chief Resident in his final year of training. He came to Cleveland Clinic in 2009 as a fellow in cardiothoracic surgery and was appointed to the medical staff in 2012 on completion of his fellowship.
Since 2000, Dr. Raja has authored more than two dozen articles in leading surgery journals on esophageal cancer, lung cancer and other thoracic diseases and contributed chapters to five medical textbooks. He has presented at meetings of the American Association for Thoracic Surgery, the Society of Thoracic Surgeons and other professional organizations.
Dr. Raja’s professional memberships include the American College of Surgeons, the American Medical Association and the General Thoracic Surgery Club. He holds two patents related to the molecular diagnosis of cancer.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/5/2015, Dr. Raja has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Royalty Payments. Dr. Raja receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.